PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29061958-0	2017	alpha-Linolenic Acid Inhibits Receptor Activator of NF-kappaB Ligand Induced (RANKL-Induced) Osteoclastogenesis and Prevents Inflammatory Bone Loss via Downregulation of Nuclear Factor-KappaB-Inducible Nitric Oxide Synthases (NF-kappaB-iNOS) Signaling Pathways.	alpha-Linolenic Acid	0-20	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	78-83	
29061958-3	2017	We investigated the effect of alpha-linolenic acid (ALA) on RANKL-stimulated osteoclast differentiation, LPS-induced and ovariectomized bone loss in mice models.	alpha-Linolenic Acid	52-55	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	60-65	
29061958-6	2017	RESULTS ALA intervention inhibited RANKL-induced osteoclasts proliferation and differentiation.	alpha-Linolenic Acid	8-11	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	35-40	
29061958-8	2017	ALA suppressed the RANKL-induced osteoclast markers c-Fos, c-Jun and NFATc1 together with transcription factor proteins TRAP, OSCAR, cathepsin K and beta3-integrin.	alpha-Linolenic Acid	0-3	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	19-24	
29061958-9	2017	ALA also suppressed the RANKL-stimulated phosphorylation of JNK, ERK, and AKT as well as NF-kappaB and BCL-2 proteins.	alpha-Linolenic Acid	0-3	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	24-29	
29061958-12	2017	CONCLUSIONS ALA suppresses RANKL-induced osteoclast differentiation and prevents inflammatory bone loss via downregulation of NF-kappaB-iNOS-COX-2 signaling.	alpha-Linolenic Acid	12-15	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	27-32